舊版 AI 分級 · 資料日期 2026-06-09。尚未採用新版自動摘要；未經專家評讀，涵蓋範圍以本頁來源為限。了解新版流程
葉酸 Folate × 心血管疾病
結論：證據不足
證據呈現明顯分歧：L2 近期 2024-2025 統合分析（45 RCT、近 10 萬人）顯示葉酸對中風有約 15% 顯著降低、對整體 CVD 有輕微 5% 下降，屬中度可信的生化代理 + 部分臨床終點效益；但對冠心病、心血管死亡率、全因死亡率均無顯著效益，且 L5 四大共識來源（Mayo、Cleveland、Harvard、ACC）一致對「葉酸預防心血管事件」採 cautious 立場，AHA 不建議用於 CVD 預防。
D 🔴 D 反證據 證據不足 🚨 high — heavy affiliate marketing in TW community
證據呈現明顯分歧：L2 近期 2024-2025 統合分析（45 RCT、近 10 萬人）顯示葉酸對中風有約 15% 顯著降低、對整體 CVD 有輕微 5% 下降，屬中度可信的生化代理 + 部分臨床終點效益；但對冠心病、心血管死亡率、全因死亡率均無顯著效益，且 L5 四大共識來源（Mayo、Cleveland、Harvard、ACC）一致對「葉酸預防心血管事件」採 cautious 立場，AHA 不建議用於 CVD 預防。
L5a（NIH ODS）亦明確將 CVD 證據評為 mixed。
效益最明顯於高同半胱胺酸、低葉酸基線、未強化食品地區，並非通用 CVD 預防介入。
綜合以「中風有限支持、整體 CVD 預防不支持」應給 C 級（mixed / 條件性效益）。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.45
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
D · 證據不足
信心度
86%
證據方向一致性高
證據層級
E1
Cochrane 高品質系統性回顧／統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.448
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 negative 主導 (2 negative > 1 positive)，下層 RCT 不能推翻
- apply_hec_override — HEC-1 高階證據 negative — 強制由 C 改為 D
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Homocysteine-lowering interventions for preventing cardiovascular events
結論：B-vitamin/folic acid supplementation showed no effect on myocardial infarction (RR 1.02, 95% CI 0.95-1.10) or all-cause mortality (RR 1.01, 95% CI 0.96-1.06), with only a modest reduction in stroke (RR 0.90, 95% CI 0.82-0.99); all three outcomes graded high-quality evidence.
前往 PubMed Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial
結論：Adding 0.8 mg folic acid to enalapril significantly reduced first stroke versus enalapril alone over 4.5 years (2.7% vs 3.4%; HR 0.79, 95% CI 0.68-0.93), in a low-folate, non-grain-fortified population.
前往 PubMed Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials
結論：Folic acid produced a small overall CVD reduction (RR 0.96, 95% CI 0.92-0.99, P=0.02) driven by stroke (RR 0.90, 95% CI 0.84-0.96, P=0.002), with no effect on coronary heart disease (RR 1.04, 95% CI 0.99-1.09, P=0.16).
前往 PubMed Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis
結論：Folic acid supplementation had no significant effect on major cardiovascular events (RR 0.98, 95% CI 0.93-1.04), stroke (RR 0.89, 95% CI 0.78-1.01), myocardial infarction (RR 1.00, 95% CI 0.93-1.07), or all-cause mortality (RR 1.00, 95% CI 0.96-1.05).
前往 PubMed Folic acid for the primary prevention of stroke: a systematic review and meta-analysis
結論：Folic acid supplementation overall did not significantly prevent first stroke (RR 0.92, 95% CI 0.80-1.05), but was effective in regions without grain fortification (RR 0.78, 95% CI 0.68-0.89).
前往 PubMed Efficacy of folic acid supplementation in the prevention of cardiovascular disease - a systematic review and meta-analysis
結論：Folic acid produced a modest CVD reduction (RR 0.95, 95% CI 0.90-0.99, P=0.04) and a stroke reduction (RR 0.85, 95% CI 0.76-0.96, P<0.01), with no benefit for mortality, coronary heart disease, peripheral arterial disease, or lipid profile.
前往 PubMed L4a US FDA
支持
Health claims relating folate to risk of neural tube defects may be made on the label or in labeling of foods, including dietary supplements, provided that the requirements in this section are met. 來源↗
L4b EU EFSA
支持
L4c UK NHS
中性
It's recommended that all women who could get pregnant should take a 400 microgram folic acid supplement daily before pregnancy and until they're 12 weeks pregnant. 來源↗
L4d TW TFDA / 衛福部
支持
孕期缺乏葉酸，會增加胎兒腦及脊髓先天性神經管缺陷的風險。育齡婦女及準備懷孕婦女可在準備階段每日攝取400微克，懷孕期間每日攝取600微克。 來源↗
L4e WHO
中性
Current evidence suggests that folic acid supplementation in the periconceptional period, either alone or in combination with other vitamins and minerals, can prevent neural tube defects. 來源↗
L5a NIH Office of Dietary Supplements
支持
L5b Mayo Clinic
謹慎
High levels of homocysteine are associated with an increased risk of cardiovascular disease, which led researchers to theorize that reducing homocysteine with folic acid therapy would also reduce cardiovascular risk. However, although taking folic acid reduces the level of homocysteine and provides protection against stroke, it doesn't appear to decrease deaths from heart attack or other cardio… 來源↗
L5c Cleveland Clinic
謹慎
Healthcare providers may prescribe B9 to lower high blood levels of homocysteine, a chemical that builds proteins (amino acids) that can harden your arteries. Both high and low levels of homocysteine (compared with moderate levels) have been associated with an increased risk of death from cardiovascular disease. But the exact link between folic acid and heart disease remains unclear. 來源↗
L5d Harvard Health
謹慎
Until recently, experts hoped that lowering homocysteine with folic acid and vitamin B6 and B12 supplements would lead to fewer heart attacks and cardiovascular events. But several large trials have been disappointing. For now, the American Heart Association doesn't recommend folic acid and B vitamin supplements to reduce the risk of heart attack or stroke. 來源↗
L5e Specialty Society (condition-mapped)
謹慎
treatment with folic acid was not associated with a reduction in the primary composite endpoint of all-cause mortality or vascular event. Based on the totality of the randomized trial data to date, homocysteine lowering with vitamin B and folic acid supplementation does not appear to be an effective secondary prevention strategy for patients with coronary heart disease. 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽
台灣社群（PTT 養生/藥學版、Mobile01 保健版）普遍認同葉酸與 B6、B12 共同代謝同半胱胺酸，間接保護血管，但少有人單獨補葉酸顧心血管，多數人是吃綜合 B 群順便獲得。社群對「葉酸預防心血管疾病」態度偏正面但保留，強調飲食優先、過量無益。
💬社群實感
意見分歧
破解迷思 社群最常見的 5 個誤解
✓
事實誤以為葉酸只是孕婦/備孕專用，與心血管無關
✓
事實把葉酸和葉黃素搞混（一個顧血管、一個顧眼睛）
✓
事實認為吃越多越好，忽略 1000 微克以上可能掩蓋 B12 缺乏
✓
事實以為單吃葉酸就能降低心臟病風險，忽略大型 RCT 結果不一致
✓
事實把含鐵葉酸錠當保健品天天吃，造成腸胃副作用
🩹 社群通報的副作用
- 噁心、胃部灼熱（多為含鐵複方）
- 尿液變深黃（B 群常見）
- 睡前吃導致睡眠變差
- 長期高劑量被提醒可能掩蓋 B12 缺乏症狀
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- DHC 葉酸
- 亞尼活力 活性葉酸
- GNC 葉酸
- 新寶納多（孕婦綜合）
- 善存銀寶（中老年綜合）
- 威瑪舒培 B 群
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 生活型態優化（健康飲食、身體活動、戒菸）
- 史他汀類藥物（適應症族群）
- 戒菸（行為介入合併藥物）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-cardiovascular-disease-INT-folate-001/",
"datePublished": "2026-06-09",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "葉酸能改善心血管疾病",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 1,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🔴 D 反證據"
}
}